
Bayesoft helps drug developers speed up trials with Bayesian statistics and AI. It enables adaptive Bayesian design to optimize clinical trials through its Adaptive Dose Optimization Platform (ADOPT) and Bayesian Estimator of Sample Size (BESS). The offerings span SaaS, Membership, and professional services, with trial design, Bayesian consultation, education, and AI-agentic solutions. Core technology includes Bayesian methods, AI, and R, serving drug development companies and clinical programs. The company highlights a global reach with 100+ trials and reductions in sample size, aiming to improve trial success rates.

Bayesoft helps drug developers speed up trials with Bayesian statistics and AI. It enables adaptive Bayesian design to optimize clinical trials through its Adaptive Dose Optimization Platform (ADOPT) and Bayesian Estimator of Sample Size (BESS). The offerings span SaaS, Membership, and professional services, with trial design, Bayesian consultation, education, and AI-agentic solutions. Core technology includes Bayesian methods, AI, and R, serving drug development companies and clinical programs. The company highlights a global reach with 100+ trials and reductions in sample size, aiming to improve trial success rates.